CMA mediates the ARPI stress response in prostate cancer, promoting ARPI treatment resistance

被引：0
|
作者：
Nikesitch, Nicholas [1 ,2 ]
Beraldi, Eliana [1 ]
Zhang, Fan [1 ]
Adomat, Hans [1 ]
Bell, Robert [1 ]
Wells, Christopher [1 ]
Saxena, Neetu [1 ]
Somasekharan, Syam Prakash [1 ]
Gleave, Andmartin [1 ,2 ]
机构：
[1] Vancouver Prostate Ctr, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
158
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] Prostate Cancer Treatment Choices RESPONSE
    Repetto, Lazzaro M.
    Abbatecola, Angela Marie
    Paolisso, Giuseppe
    ANNALS OF INTERNAL MEDICINE, 2013, 159 (06) : 436 - 436
  • [32] Treatment Response Imaging in Prostate Cancer
    Swiha, Mina
    Gafita, Andrei
    Nguyen, Andrew
    Emmett, Louise
    PET CLINICS, 2024, 19 (03) : 417 - 430
  • [33] The endoplasmic reticulum stress response in prostate cancer
    de la Calle, Claire M.
    Shee, Kevin
    Yang, Heiko
    Lonergan, Peter E.
    Nguyen, Hao G.
    NATURE REVIEWS UROLOGY, 2022, 19 (12) : 708 - 726
  • [34] The endoplasmic reticulum stress response in prostate cancer
    Claire M. de la Calle
    Kevin Shee
    Heiko Yang
    Peter E. Lonergan
    Hao G. Nguyen
    Nature Reviews Urology, 2022, 19 : 708 - 726
  • [35] Oxidative stress is inherent in prostate cancer cells and mediates aggressive phenotype
    Kumar, Binod
    Koul, Sweaty
    Khandrika, Lakshmipathi
    Meacham, Randall B.
    Koul, Hari K.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 192 - 193
  • [36] Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy.
    Mandel, Philipp
    Hoeh, Benedikt
    Siech, Carolin
    Koll, Florestan
    Humke, Clara
    Groener, Daniel
    Steuber, Thomas
    Graefen, Markus
    Maurer, Tobias
    Banek, Severine
    Chun, Felix
    Wenzel, Mike
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [37] Contribution of cancer associated fibroblasts to treatment response and resistance in high-risk multifocal prostate cancer
    Lupsa, Nikolett
    Heninger, Erika
    Ding, Adeline
    Reese, Shannon R.
    Hazelberg, Xavier T.
    LeBeau, Aaron M.
    Johnson, Brian P.
    Geiger, Peter P.
    Beebe, David J.
    Quigley, David A.
    Lang, Joshua M.
    CANCER RESEARCH, 2024, 84 (06)
  • [38] Biomarker predicts treatment resistance in prostate cancer
    Wilkinson, Emma
    LANCET ONCOLOGY, 2014, 15 (11): : E483 - E483
  • [39] Altered stress hormone response following acute exercise during prostate cancer treatment
    Hanson, E. D.
    Sakkal, S.
    Evans, W. S.
    Violet, J. A.
    Battaglini, C. L.
    McConell, G. K.
    Hayes, A.
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2018, 28 (08) : 1925 - 1933
  • [40] ARHGEF2 REGULATES LINEAGE PLASTICITY PROMOTING NEUROENDOCRINE DIFFERENTIATION AND TREATMENT RESISTANCE IN ADVANCED PROSTATE CANCER
    Ning, Shu
    Lou, Wei
    Lombard, Alan
    Sharifi, Masuda
    Schaaf, Zachary
    Evans, Christopher
    Gao, Allen
    JOURNAL OF UROLOGY, 2023, 209 : E276 - E276
12345